SNP Genotyping and Analysis Market Analysis | Coherent Market Insights

1
Coherent Market InsightS

• Market Research and Business Consulting
  Services
• https//www.coherentmarketinsights.com/
• COVID-19 Impact Tracker

2
SNP Genotyping and Analysis Market Analysis
(2020-2027)

• Single Nucleotide Polymorphism (SNP) represents
  the most common type of mutation in genomes of
  all life forms. SNP genotyping is the measurement
  of genetic variations of SNPs between members of
  a species.
• The global SNP genotyping and analysis market is
  estimated to account for US 11,553.0 Mn in terms
  of value in 2020 and is expected to reach US
  46,268.9 Mn by the end of 2027.

3
Global SNP Genotyping and Analysis Market
Drivers

• Increasing prevalence of genetic disorders is
  expected to propel growth of the global SNP
  genotyping and analysis market over the forecast
  period. For instance, according to Summary of the
  Cystic Fibrosis Foundation Patient Registry,
  20032018, the number of people with cystic
  fibrosis increased from 21,421 in 2003 to 30,775
  in 2018.
• Moreover, collaborative efforts to enhance
  personalized medicine is also expected to aid in
  growth of the market. For instance, in April
  2020, Indivumed GmbH, an oncology company,
  launched the Oncology Alliance for Individualized
  Medicine, an international collaborative alliance
  to advance personalized medicine in cancer
  through IndivuType, the companys multi-omics
  database.

4

• SNP Microarray held dominant position in the
  global SNP genotyping and analysis market in
  2019, accounting for 37.9 share in terms of
  value, followed by Taqman Allelic Discrimination
  and Others, respectively.

5
Figure 1. Global SNP Genotyping and
Analysis Market Share (), by Value, by
Technology, 2019
6
Global SNP Genotyping and Analysis Market
Restraints

• Imperfect protocols leading to large redundant
  data are expected to hinder growth of the market.
  Several areas such as diagnostics within the
  genotyping segment are currently yet to reveal
  themselves as potential markets. Although
  diagnostics has been closely associated with SNP
  genotyping, currently the genotyping technique
  only serves as a research tool in diagnostics
  instead of being able to conduct a diagnostic
  test.
• Moreover, despite the high accuracy of short read
  sequencing, there are still issues with attaining
  accurate SNP genotypes at low sequencing coverage
  and in highly duplicated genomes due to
  misalignment, which is also expected to limit
  growth of the market.

7
(No Transcript)
8
Global SNP Genotyping and Analysis Market
Opportunities 

• Increasing adoption of SNP genotyping in farm
  animal gene exploration is expected to offer
  lucrative growth opportunities for players in the
  global SNP genotyping and analysis market. For
  instance, in April 2020, researchers from Jung P
  C Institute, Inc., South Korea, used Bayesian
  methods under different genotyping platforms to
  perform genomic analysis in Korean Duroc pigs.
• Moreover, genomic, retrospective, multicenter
  analysis of cancer is also expected to aid in
  growth of the market.

9

• For instance, in June 2020, a study presented via
  the virtual Society of Gynecologic Oncology 2020
  Annual Meeting on Women's Cancer, reported
  examining a large clinical dataset of low-grade
  serous ovarian cancer through the Ovarian Cancer
  Association Consortium, with the primary goal of
  identifying factors that affect survival.
• The global SNP genotyping and analysis market was
  valued at US 9,485.2 Mn in 2019 and is forecast
  to reach a value of US 46,268.9 Mn by 2027 at a
  CAGR of 21.9 between 2020 and 2027.

10
 Global eHealth Software and Services Market
Opportunities 

• Launch of telemedicine programs is expected to
  offer lucrative growth opportunities for players
  in the global eHealth software and services
  market. For instance, in March 2020, UK
  HealthCare launched a new telemedicine program to
  help prevent the spread of the novel coronavirus.
• Moreover, increasing adoption of cloud-based PACS
  is also expected to aid in growth of the market.
  Cloud-based PACS offers several benefits such as
  on-demand self-service, broad network access,
  resource pooling, rapid elasticity, and measured
  service.
• The global eHealth software and services market
  was valued at US 187.7 Bn in 2019 and is
  forecast to reach a value of US 458.3 Bn by 2027
  at a CAGR of 11.8 between 2020 and 2027.

11
Figure 2. Global SNP Genotyping and
Analysis Market Value (US Mn), and Y-o-Y Growth
(), 2019-2027
12
Market Trends/Key Takeaways

• Major players in the market are focused on
  adopting MA strategies to expand their product
  portfolio. For instance, in February 2020,
  Fluidigm Corporation acquired InstruNor AS, a
  privately held provider of fully integrated
  sample preparation system for flow and mass
  cytometry.
• Major players in the market are focused on
  investing in targeted therapies. For instance, in
  October 2018, Thermo Fisher Scientific
  facilitated the next phase of the FinnGen
  precision medicine study that aims to deepen the
  overall understanding of chronic disease
  mechanisms in the Finnish population.

13
Global SNP Genotyping and Analysis Market
Competitive Landscape

• Major players operating in the global SNP
  genotyping and analysis market include, LGC
  Limited, Fluidigm Corporation, Illumina, Inc.,
  Life Technologies Corporation, PREMIER Biosoft,
  Thermo Fisher Scientific, and Sequenom, Inc.

14
Global SNP Genotyping and Analysis Market Key
Developments

• Major players in the market are focused on
  launching new products to expand their product
  portfolio. For instance, in July 2019, Thermo
  Fisher Scientific launched three new Applied
  Biosystems AgriSeq targeted genotyping by
  sequencing solutions that will allow customers to
  genotype canines and felines.

15

• Request sample copy here
• Request PDF brochure here
• Request Customization here
• Talk to Analyst
• Buy Now
• Reference
• https//www.coherentmarketinsights.com/market-insi
  ght/snp-genotyping-and-analysis-market-3972

16
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions.
• What we provide
• Customized Market Research Services
• Industry Analysis Services
• Business Consulting Services
• Market Intelligence Services
• Long term Engagement Model
• Country Specific Analysis

17
Contact Us   

• Mr. Shah
• Coherent Market Insights Pvt. Ltd.
• Address 1001 4th ave, 3200 Seattle, WA 98154,
  U.S.
• Phone [phone]
• Email sales_at_coherentmarketinsights.com

18
Thank You!

• Kindly follow CMI Social Media Profiles for the
  latest company updates
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/